BKG VET PHARMA ApS: Financial statements 2017
CVR: 34044341
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
BKG VET PHARMA ApS (CVR 34044341) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -150,876 and a net result of DKK -329,327 compared with DKK -6,127,989 the year before. Equity in the 2017 report amounted to DKK 520,559. The solvency ratio was 86.4%.
- Gross Profit
- DKK -150,876
- Profit/Loss
- DKK -329,327
- Equity
- DKK 520,559
- Total Assets
- DKK 602,470
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -151 t. | -329 t. | 521 t. | - |
| 2016 | - | -94 t. | -6.1 mio. | 850 t. | - |
| 2015 | - | -125 t. | -629 t. | 7 mio. | - |
| 2014 | - | -120 t. | -42 t. | 7.6 mio. | - |
| 2013 | - | -89 t. | 93 t. | 7.6 mio. | - |
Official annual report
Keep an eye on BKG VET PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of November 14, 2017, Birgit Kjældgaard has left the board of directors of BKG VET PHARMA ApS.
As of November 14, 2017, Christian Fink Hansen has left the board of directors of BKG VET PHARMA ApS.
As of November 14, 2017, Peter Christian Kierkegaard is registered as liquidator of BKG VET PHARMA ApS.
As of November 14, 2017, Rasmus Schmiegelow has stepped down as chairman of BKG VET PHARMA ApS.
As of November 14, 2017, Birgit Kjældgaard has stepped down as direktion of BKG VET PHARMA ApS.
On November 14, 2017, BKG VET PHARMA ApS entered liquidation.
BKG VET PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -94,192, and the net result was DKK -6,127,989.
As of March 6, 2017, Christian Fink Hansen has joined the board of directors of BKG VET PHARMA ApS.
As of January 1, 2017, Claus Fertin has left the board of directors of BKG VET PHARMA ApS.
About BKG VET PHARMA ApS
BKG VET PHARMA ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2011. The company has been dissolved on 31 March 2020. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2017). In 2018, the company reported a gross profit of DKK -36,050 and a net result of DKK -94,791 compared with DKK -329,327 the year before. Equity in the 2018 report amounted to DKK 225,768.